期刊文献+

系统性红斑狼疮小鼠脾细胞中IL-12信号传递途径的研究 被引量:2

IL-12 signaling pathway through Lck / p38 / c-jun in splenocytes from systemic lupus ery- thematosus mouse
原文传递
导出
摘要 目的探讨在狼疮小鼠脾细胞中是否存在IL-12通过Lck/P38/c-jun传递信号及其对脾细胞的影响。方法以慢性移植物抗宿主病(graft versus host disease, GVHD)小鼠为狼疮小鼠模型,分别采用放射自显影、 Western blot和Northern blot,检测培养的脾细胞中 Lck的活性、 p38磷酸化活化及c-jun基因表达的变化。结果狼疮小鼠脾细胞经IL-12刺激后,与正常对照组相比较,Lck的活性增高、p38异常活化,c-jun mRNA的水平增高。加入Lck抑制剂 PP1组Lck的活性及p38磷酸化消失,无c-jun基因的表达;加入p38抑制剂SB203580组亦无p38磷酸化及c-jun基因的表达。结论狼疮小鼠的脾细胞异常,IL-12可通过Lck/p38/c-jun在细胞内传递信号,直接参与免疫损伤。 Aim To investigate whether there is IL-12 signaling pathway through lck/p38/c -jun in splenic cells obtained from lupus mouse and its effect on splenic cells. Methods Mice with graft versus host disease were used as lupus nephritis model. Activity of Lck tyrosine kinase, p38 phosphorylation and mRNA expression of c-jun in splenic cells were determined by autoradiography, Western blot and Northern blot, respectively. Results There were higher levels of Lck activity, p38 phosphorylation and c-jun expression of IL-12-stimulated splenic cells from lupus model when compared with that observed in similarly treated splenic cells from normal control. The Lck activity and p38 phosphorylation were almost inhibited by Lck inhibitor PP1, on the other hand, p38 specific inhibitor SB203580 decreased phosphorylation of p38. In addition, expression of c-Jun was also inhibited by PP1 or SB203580 although splenic cells were stimulated with IL-12. Conclusion Aberrant murine splenic call, IL-12-me- diated intracelluar signaling pathway through lck/p38/c-Jun were involved in immunologic damage.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2001年第1期32-34,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 卫生部基金资助!No.94-1-105
关键词 系统性红斑狼疮 脾细胞 IL-12 信号传递途径 interleukin-12 Lck p38 systemic lupus erythematosus splenocyte
  • 相关文献

参考文献6

二级参考文献5

  • 1谢春 叶任高 等.一种狼疮性肾炎的活动性指数[J].中华肾脏病杂志,1997,4:206-208.
  • 2吴余升 李艳崇 等.川芎嗪对体外培养的淋巴细胞DNA合成的影响[J].陕西新医药,1983,12:54-56.
  • 3谢春,中华肾脏病杂志,1997年,4卷,206页
  • 4叶任高,肾脏病诊断与治疗学,1994年,271页
  • 5吴余升,陕西新医药,1983年,12卷,54页

共引文献9

同被引文献7

  • 1李艳波,汪恕萍.p38 MAPK信号传递通路与糖尿病血管并发症[J].国外医学(内科学分册),2002,29(3):119-121. 被引量:4
  • 2Lee JC,Young PR.Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms[J].J Leukoc Biol,1996,59(2):152-157.
  • 3Han J,Jiang Y,Li Z,et al.Activation of the transcription factor MEF2C by the MAP kinase P38 in inflammation[J].Nature,1997,386(6622):296-299.
  • 4Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N Engl J Med,1995,333(20):1301-1307.
  • 5Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events Trial investigators[J].N Engl J Med,1996,335(14):1001-1009.
  • 6Bogoyevitch MA,Gillespie-Brown J,Ketterman AJ,et al.Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart.p38/RK mitogen-activated protein kinases and c-jun N-terminal kinases are activated by ischemia/reperfusion[J].Circ Res,1996,79(2):162-173.
  • 7Schaper NC.Early atherogenesis in diabetes mellitus [J].Diabet Med,1996,13 (suppl 1):S23-25.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部